JP2014501513A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014501513A5 JP2014501513A5 JP2013541012A JP2013541012A JP2014501513A5 JP 2014501513 A5 JP2014501513 A5 JP 2014501513A5 JP 2013541012 A JP2013541012 A JP 2013541012A JP 2013541012 A JP2013541012 A JP 2013541012A JP 2014501513 A5 JP2014501513 A5 JP 2014501513A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- variable region
- chain variable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41692710P | 2010-11-24 | 2010-11-24 | |
| US61/416,927 | 2010-11-24 | ||
| PCT/US2011/061785 WO2012071381A1 (en) | 2010-11-24 | 2011-11-22 | Antibodies to notum pectinacetylesterase |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014501513A JP2014501513A (ja) | 2014-01-23 |
| JP2014501513A5 true JP2014501513A5 (enExample) | 2014-12-25 |
| JP6033229B2 JP6033229B2 (ja) | 2016-11-30 |
Family
ID=46146184
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013541012A Expired - Fee Related JP6033229B2 (ja) | 2010-11-24 | 2011-11-22 | Ｎｏｔｕｍペクチンアセチルエステラーゼと結合する抗体 |
Country Status (21)
| Country | Link |
|---|---|
| US (3) | US20130302346A1 (enExample) |
| EP (1) | EP2643019B1 (enExample) |
| JP (1) | JP6033229B2 (enExample) |
| KR (2) | KR20180069083A (enExample) |
| CN (1) | CN103298490B (enExample) |
| AU (1) | AU2011332007C1 (enExample) |
| BR (1) | BR112013012858B1 (enExample) |
| CA (1) | CA2817415C (enExample) |
| CO (1) | CO6721048A2 (enExample) |
| DK (1) | DK2643019T3 (enExample) |
| ES (1) | ES2718849T3 (enExample) |
| HU (1) | HUE043576T2 (enExample) |
| IL (1) | IL225876A0 (enExample) |
| MX (2) | MX385858B (enExample) |
| NZ (1) | NZ609501A (enExample) |
| PL (1) | PL2643019T3 (enExample) |
| PT (1) | PT2643019T (enExample) |
| RU (1) | RU2013123793A (enExample) |
| SG (1) | SG189982A1 (enExample) |
| WO (1) | WO2012071381A1 (enExample) |
| ZA (1) | ZA201302983B (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20130224191A1 (en) * | 2010-08-27 | 2013-08-29 | Robert A. Stull | Notum protein modulators and methods of use |
| RU2013123793A (ru) | 2010-11-24 | 2014-12-27 | Лексикон Фармасьютикалз, Инк. | Антитела, связывающиеся с notum пектинацетилэстеразой |
| CA2858350A1 (en) | 2011-01-14 | 2013-07-19 | The Regents Of The University Of California | Therapeutic antibodies against ror-1 protein and methods for use of same |
| US8802365B2 (en) * | 2011-03-22 | 2014-08-12 | Whitehead Institute For Biomedical Research | Methods for identifying candidate modulators of NOTUM activity |
| EP2977386A1 (en) * | 2012-08-31 | 2016-01-27 | Argen-X Nv | Method for producing antibody molecules having inter-species, intra-target cross-reactivity |
| SG11201706583PA (en) | 2015-02-19 | 2017-09-28 | Compugen Ltd | Anti-pvrig antibodies and methods of use |
| SG11201901077RA (en) | 2016-08-17 | 2019-03-28 | Compugen Ltd | Anti-tigit antibodies, anti-pvrig antibodies and combinations thereof |
| WO2020150282A1 (en) * | 2019-01-18 | 2020-07-23 | Askgene Pharma Inc. | Pd-l1 specific monoclonal antibodies for disease treatment and diagnosis |
| CN110317271B (zh) * | 2019-07-02 | 2021-04-30 | 武汉云克隆科技股份有限公司 | 一种pinp重组抗体的重/轻链可变区及编码基因和重组抗体 |
| EP4263613A4 (en) * | 2020-12-16 | 2024-11-20 | Memorial Sloan-Kettering Cancer Center | CD40-BINDING MOLECULES AND USES THEREOF |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3773919A (en) | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
| US4179337A (en) | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
| US4263428A (en) | 1978-03-24 | 1981-04-21 | The Regents Of The University Of California | Bis-anthracycline nucleic acid function inhibitors and improved method for administering the same |
| IE52535B1 (en) | 1981-02-16 | 1987-12-09 | Ici Plc | Continuous release pharmaceutical compositions |
| DE3374837D1 (en) | 1982-02-17 | 1988-01-21 | Ciba Geigy Ag | Lipids in the aqueous phase |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| HUT35524A (en) | 1983-08-02 | 1985-07-29 | Hoechst Ag | Process for preparing pharmaceutical compositions containing regulatory /regulative/ peptides providing for the retarded release of the active substance |
| US4615885A (en) | 1983-11-01 | 1986-10-07 | Terumo Kabushiki Kaisha | Pharmaceutical composition containing urokinase |
| EP0154316B1 (en) | 1984-03-06 | 1989-09-13 | Takeda Chemical Industries, Ltd. | Chemically modified lymphokine and production thereof |
| WO1990006952A1 (fr) | 1988-12-22 | 1990-06-28 | Kirin-Amgen, Inc. | Facteur de stimulation de colonies de granulocytes modifies chimiquement |
| ES2284161T3 (es) | 1990-01-12 | 2007-11-01 | Amgen Fremont Inc. | Generacion de anticuerpos xenogenicos. |
| US6075181A (en) | 1990-01-12 | 2000-06-13 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
| US6552170B1 (en) | 1990-04-06 | 2003-04-22 | Amgen Inc. | PEGylation reagents and compounds formed therewith |
| GEP20033082B (en) | 1991-03-15 | 2003-10-27 | Amgen Inc | Pegylation of Polypeptides |
| US5446090A (en) | 1993-11-12 | 1995-08-29 | Shearwater Polymers, Inc. | Isolatable, water soluble, and hydrolytically stable active sulfones of poly(ethylene glycol) and related polymers for modification of surfaces and molecules |
| US5824784A (en) | 1994-10-12 | 1998-10-20 | Amgen Inc. | N-terminally chemically modified protein compositions and methods |
| TW313568B (enExample) | 1994-12-20 | 1997-08-21 | Hoffmann La Roche | |
| US6127977A (en) | 1996-11-08 | 2000-10-03 | Cohen; Nathan | Microstrip patch antenna with fractal structure |
| ATE549918T1 (de) | 1996-12-03 | 2012-04-15 | Amgen Fremont Inc | Menschliche antikörper, die ausdrücklich menschliches tnf alpha binden |
| US6080576A (en) | 1998-03-27 | 2000-06-27 | Lexicon Genetics Incorporated | Vectors for gene trapping and gene activation |
| GB0201808D0 (en) * | 2002-01-25 | 2002-03-13 | European Molecular Biology Lab Embl | Protein |
| US20040063924A1 (en) * | 2002-01-28 | 2004-04-01 | Y Tom Tang | Secreted proteins |
| EP1652923B1 (en) * | 2003-08-08 | 2011-10-12 | Perseus Proteomics Inc. | Gene overexpressed in cancer |
| US20130224191A1 (en) * | 2010-08-27 | 2013-08-29 | Robert A. Stull | Notum protein modulators and methods of use |
| RU2013123793A (ru) | 2010-11-24 | 2014-12-27 | Лексикон Фармасьютикалз, Инк. | Антитела, связывающиеся с notum пектинацетилэстеразой |
-
2011
- 2011-11-22 RU RU2013123793/10A patent/RU2013123793A/ru not_active Application Discontinuation
- 2011-11-22 HU HUE11843652A patent/HUE043576T2/hu unknown
- 2011-11-22 MX MX2018001218A patent/MX385858B/es unknown
- 2011-11-22 WO PCT/US2011/061785 patent/WO2012071381A1/en not_active Ceased
- 2011-11-22 DK DK11843652.6T patent/DK2643019T3/en active
- 2011-11-22 US US13/885,815 patent/US20130302346A1/en not_active Abandoned
- 2011-11-22 PL PL11843652T patent/PL2643019T3/pl unknown
- 2011-11-22 SG SG2013031083A patent/SG189982A1/en unknown
- 2011-11-22 EP EP11843652.6A patent/EP2643019B1/en not_active Not-in-force
- 2011-11-22 CA CA2817415A patent/CA2817415C/en active Active
- 2011-11-22 ES ES11843652T patent/ES2718849T3/es active Active
- 2011-11-22 CN CN201180056452.6A patent/CN103298490B/zh not_active Expired - Fee Related
- 2011-11-22 KR KR1020187016214A patent/KR20180069083A/ko not_active Ceased
- 2011-11-22 KR KR1020137013390A patent/KR20140026334A/ko not_active Ceased
- 2011-11-22 NZ NZ609501A patent/NZ609501A/en not_active IP Right Cessation
- 2011-11-22 JP JP2013541012A patent/JP6033229B2/ja not_active Expired - Fee Related
- 2011-11-22 MX MX2013005906A patent/MX357166B/es active IP Right Grant
- 2011-11-22 AU AU2011332007A patent/AU2011332007C1/en not_active Ceased
- 2011-11-22 PT PT11843652T patent/PT2643019T/pt unknown
- 2011-11-22 BR BR112013012858-5A patent/BR112013012858B1/pt not_active IP Right Cessation
-
2013
- 2013-04-22 IL IL225876A patent/IL225876A0/en active IP Right Grant
- 2013-04-24 ZA ZA2013/02983A patent/ZA201302983B/en unknown
- 2013-06-24 CO CO13149527A patent/CO6721048A2/es not_active Application Discontinuation
-
2015
- 2015-11-25 US US14/952,264 patent/US20160152731A1/en not_active Abandoned
-
2019
- 2019-02-15 US US16/277,466 patent/US11059907B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN109517065B (zh) | Il-18结合分子 | |
| RU2495050C2 (ru) | Связующий элемент для рецептора gm-csf | |
| CA2758252C (en) | Dkk-1 antibodies | |
| JP2018521691A5 (enExample) | ||
| JP2009511480A5 (enExample) | ||
| JP2019522961A5 (enExample) | ||
| JP2013538553A5 (enExample) | ||
| JP2006512899A5 (enExample) | ||
| JP2014500009A5 (enExample) | ||
| JP2015503909A5 (enExample) | ||
| JP2014524748A5 (enExample) | ||
| JP2011518886A5 (enExample) | ||
| JP6875275B2 (ja) | Ｌ１ｃａｍ（ｃｄ１７）と結合する抗体などの結合分子 | |
| JP2008542278A5 (enExample) | ||
| JP2018521638A5 (enExample) | ||
| JP2014534806A5 (enExample) | ||
| JP2012513214A5 (enExample) | ||
| HRP20140618T1 (hr) | Protutijela protiv beta-amiloidnog peptida | |
| HRP20140108T1 (hr) | Protutijela protiv sklerostina | |
| JP2015529641A5 (enExample) | ||
| HRP20150799T1 (hr) | Sastavi i postupci za protutijela protiv komplementnog proteina c5 | |
| RU2013123793A (ru) | Антитела, связывающиеся с notum пектинацетилэстеразой | |
| RU2016100892A (ru) | Антитела против tweakr и их применение | |
| JP2020522280A5 (enExample) | ||
| JP2021500916A5 (enExample) |